MedTrace Logo

Maternal Autoimmune Thyroid Disease and Fetal Thyroxin

NCT01528904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 83

Last updated 2012-02-08

No results posted yet for this study

Summary

The purpose of this trial is to correlate fetal thyroid hormones from fetal cord blood with clinical (maternal antithyroid drug dose and antithyroid antibodies) and ultrasound (US) parameters of fetal thyroid function from pregnant mothers with autoimmune thyroid disease (AITD).

Conditions

  • Pregnancy Complicated by Hyperthyroidism
  • Hypothyroidism in Pregnancy

Sponsors & Collaborators

  • University of Belgrade

    lead OTHER

Principal Investigators

  • Svetlana Spremovic-Radjenovic, MD PhD · Medical School of the University of Belgrade

Eligibility

Min Age
23 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-31
Primary Completion
2011-03-31
Completion
2011-06-30

Countries

  • Serbia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01528904 on ClinicalTrials.gov